Part:BBa_K2382011
Anti-antitoxin scFv
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI site found at 339
Illegal SapI.rc site found at 252
Usage and Biology
This is the single chain variable fragment (scFv) of an antibody that have ability of binding aflatoxin. Since bacteria cannot produce the whole antibody, we decide to use scFv to replace it. It contains two polypeptide chains linked by a GS linker.
Contents
Characterization of the Anti-antitoxin scFv
Expression results
Initially when we were designing the sequence of scFv, our plan was to replace the coloring function of gold nanoparticle with RFP(BBa_K2382010). But the colonies we got after the first transformation did not present visible red colors as we expected. We were not sure whether the problem came from RFP itself, or the function of RFP being affected by other proteins, causing it to fail to show desired results. After the fusion protein purification, we obtained a 57kDa single band that is the same size as our protein, so we were sure that the fusion protein has been produced (Fig.10).
Later we analyzed the binding capacity of the purified protein. In the experiment we first went through dialysis of excess salt and then diluted the samples 2000 and 4000 times before doing ELISA assay. After our test, only 2000 times dilution of the protein seems to perform a bit of affinity (Fig. 11).
ELISA
However, we doubted that the result might be interrupted by salt in buffer. Therefore, we narrowed the dilution range to 2000 times to 4000 times (Fig. 12), and desalted before ELISA assay. If antibody have binding ability, the O.D value would change with AFB1 level. Theoretically, the OD we measured would increase with the concentration of aflatoxin. However, the trend line did not follow this rule; the antibody may not perform any binding ability. Unfortunately from the final results we can only judge that the fusion protein does not have any binding ability.
After subsequent discussion with the instructor, we suspect that the binding ability of scFv is fine, but after the addition of other proteins, the original binding ability may have been change, which led to the loss of the original function.
References
(1)Morrison SL. Cloning, expression, and modification of antibody V regions. Curr Protoc Immunol. 2002 May;Chapter 2:Unit 2.12. doi: 10.1002/0471142735.im0212s47.
(2)Biing-Hui Liu, KuangeChun Chu, Feng-Yih Yu. Novel monoclonal antibody-based sensitive enzyme-linked immunosorbent assay and rapid immunochromatographic strip for detecting aflatoxin M1 in milk. Food Control 66 (2016) 1-7
(3)Reddy Chichili, V. P., Kumar, V., & Sivaraman, J. (2013). Linkers in the structural biology of protein–protein interactions. Protein Science : A Publication of the Protein Society, 22(2), 153–167. http://doi.org/10.1002/pro.2206
(4): X. Chen, et al., Fusion protein linkers: Property, design and functionality, Adv. Drug Deliv. Rev. (2012), http:// dx.doi.org/10.1016/j.addr.2012.09.039
(5)Xin Li, Peiwu Li, Qi Zhang, Yuanyuan Li, Wen Zhang & Xiaoxia Ding. Molecular Characterization of Monoclonal Antibodies against Aflatoxins: A Possible Explanation for the Highest Sensitivity. © 2012 American Chemical Society dx.doi.org/10.1021/ac202747u | Anal. Chem. 2012, 84, 5229−5235
//collections/immune_regulation/antibodies
protein | Anti-aflatoxin scFv |